Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
about
Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry.What are the most promising strategies for the therapeutic immunomodulation of allergic diseases?Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.Herpesvirus infections in organ transplant recipientsThe pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus diseaseCritical care perspective on immunotherapy in lung transplantation.Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation.Increased incidence of adenoidectomy and tonsillectomy in children with renal transplantation.Epstein-Barr virus infection in children with renal transplantation: 17 years experience at a single center.Predicting outcome from post-transplant lymphoproliferative disease: a risky business.The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study).Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.
P2860
Q30706852-E45CB8D7-5287-4B6F-AAB9-FD9FA2C67141Q34190563-CE5F793A-CA2B-4FFC-8246-121A0DDB3054Q34271690-CFB225DC-6994-4D16-8108-00ACCA819F4CQ34275888-B83419D7-B76B-4B3B-B33F-FE9DE718D835Q34293457-8BAE6264-6711-4E36-8FFF-CF2E79A59F19Q34579836-DBD0496B-5474-4951-A129-6E5920EA329AQ35683931-E441AEC1-6AE1-4967-B803-56D90E6B699CQ36649380-C2071972-81AF-44EB-8D65-25CD80022B65Q38392458-62A2D8AC-7CB7-49F0-B4FB-5DB0DBE21D9BQ38933152-F09FBBC9-D0E6-45C3-AF5E-68A15BA275ACQ40102118-31785E24-1266-4D37-9AB7-513304597CACQ40584058-9CE5DFAC-79D0-4845-91EE-8423D2C096B0Q42234395-8B2B2451-0584-4764-B204-E5A4E31679A6Q42234878-AF828901-0DE6-4EA3-AE5F-BEB18D6FEFC3Q43714299-187550C3-DDBA-4DB8-B93B-11D11F70DD6FQ43900332-317AC8AD-3FFE-4D9A-8EA6-845FB6C12464Q45450388-40318ADD-46B3-472B-BA0B-8975D21A2D20Q46718321-E440D7C2-F50C-47E3-BA8C-C1C9985229E9Q52646026-A395FF86-3153-41AB-BFF3-01A2C7A403AEQ52739813-E488CCA9-2B94-4769-AEBC-27F4B82EDBC6
P2860
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@en
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@nl
type
label
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@en
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@nl
prefLabel
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@en
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@nl
P2093
P1433
P1476
Epstein-Barr virus-related dis ...... limus-based immunosuppression.
@en
P2093
Janosky JJ
Lombardozzi-Lane S
Scantlebury V
P304
P356
10.1097/00007890-199910150-00017
P577
1999-10-01T00:00:00Z